Feed/Companies/Consano Bio, Inc.

Consano Bio, Inc.

As of 14 Oct 2026, Consano Bio, Inc. has raised $15M across 1 verified round on record; latest: $15M Series A led by Conviction Partners, announced 10 Sep 2026.

BUILT ON

A clinical-stage biotechnology company advancing novel therapeutics designed to address serious, painful orthopedic conditions

consanobio.comLinkedInGreater Boston areaBiotech

LATEST ROUND

Series A

$15M · 2026-09-10

RAISED ON RECORD · USD

$15M

1 verified round · $45M to date, as reported

INVESTORS

1 lead

SOURCES

from 8 publishers

Feed/Companies

Company

Every round on record, with the sources behind each and the investors on them.

BUILT ON

Series ASeries A+

$15M · 2026-09-10

[ REPORTED LATER ]

led by Conviction Partners

Round	Amount	Announced	Lead	Buzz
Series A Series A+ [ REPORTED LATER ]: This round was announced before Fireround first saw it. It stays in the company's history, not in Latest, Trending, or alerts.	$15M $45M to date	2026-09-10	Conviction Partners	No recent discussion
9 sources [ VERIFIED ] read against 1 of 9 sources

Consano Bio, Inc.

Company

Rounds

Sources

Profile

Investors

Consano Bio, Inc.

Rounds

Profile

Sources

Series A$15M2026-09-109 sources

Investors

Series A$15M2026-09-101 investor